{"name":"Oxford BioTherapeutics Ltd","slug":"oxford-biotherapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxQWlhDY1Z0VkYySzJVMzVVdHhpYklYcmxGelpYUnZkODdnWWdCM3dDT0ttX1A1OE0wOTMyUlpUdFg3Yld5MEVoVWlDYUdUS0k0S2pXRXhrdG4xd2VyMDhzb2RqdU1ZRlY5VHd5Mmw4U05pNGZQczNKSVpYcUxEMHlUblpOOGVzYWZ0QkFmNVphRGQxYTc1Z1phX3A1REdsSGcxQUoybmZOSWZJbGtZSzJiMUdPUVliV0tWOWNybm9VNHFTaE1xNVRKQjNJZm9majdWdjIyM0FaX0k4SHRlM2twSkhULS1OTnZtNHVUNFRrZl9MVkp3NGJ2QmJPZ0ZhR0ZFT1I4eURGLTB5dTB6UFc4RWFjdDFaM0hpVTZ6alVRLWNqRkRnN1BHUHQzem1ZM2JiMnpMWUJGc2J0aEMwMHE5LUZKMG9aZjUwMWFFWm5YX1d1WVU?oc=5","date":"2026-03-09","type":"pipeline","source":"PR Newswire","summary":"Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight - PR Newswire","headline":"Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUGt4c3FQX0hDVzNPaVl6clV4TFk1NGhtZXBFZWtTV1g4YjVQZ1dFLS1iVXZyWkhGd0xnVE9hVXlmMi1NUEtVUGp2QTV0SGdVUzZud3BjMkZXTkFjU3ZBbDNTc2QwNjFPQ3NOWkgyczdGay1CRTlsX3JuREVieGRrVk1LREVJYlozMGduc3hJVUlMbEdZQ19idE1JcEExdUx2c1FROFAzWFFMYjNSRzFGNnJadUppWC1Ud3ZR?oc=5","date":"2026-02-04","type":"deal","source":"Contract Pharma","summary":"OXB and BMS Expand Partnership With Lentiviral Vectors for CAR-T Programs - Contract Pharma","headline":"OXB and BMS Expand Partnership With Lentiviral Vectors for CAR-T Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb2pxbHltVkJOVWNHYUxqdW9STXZxdHZNYlRTeFZ4Z1ZpdGVNczlQS21kaktncU5uSHMyR1VXWTJKLVlDUFpVejhPcXdJUVhrU1RBVi1tVE9WbUpsWWt6S0hGTGJ6YmY1M3dlUmRyaTNYcjUxNDcxUzE5VEJLVmRhOVEwcS1UT2tv?oc=5","date":"2026-01-06","type":"pipeline","source":"pharmaphorum","summary":"Amgen inks $840m takeover of UK's Dark Blue Therapeutics - pharmaphorum","headline":"Amgen inks $840m takeover of UK's Dark Blue Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPN015NXNvbHVMa3lVMjEzSUhyUkIzNkl2VEtuQVFQMU5uZV9wSWFDTkhaQUZnekxQMGcxcTliNmpUUmdYUWZtOVdpNktNUTNzRzl6WldoTTMwdXVWd3RMX0pHd2lUWlJ4MFZJUFdTOUlIWGFEbk81Y0hSRmRlR3Jqa1hEYllBbTUyMUE?oc=5","date":"2025-12-10","type":"regulatory","source":"Yahoo Finance UK","summary":"GSK Bolsters Oncology Pipeline with New US FDA Designation, Oxford BioTherapeutics Partnership - Yahoo Finance UK","headline":"GSK Bolsters Oncology Pipeline with New US FDA Designation, Oxford BioTherapeutics Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNLW1MSHE4SExGcUxETi01YkpVanU4OElseUJVU21sSkNMQ3NiTENGZUNUcGFIQjBJa0JzZWxWUWQ1YktaenkwdTFRVEtUY1lScC0tNU5USlN0cVNROGFzRlRhaE9mS3BzYWRhUE9aNVRuTEd2TnRTRWxpZ2RmYkhNbHdzYU5QM2V5TjdGUFJVTkd3ZXNRZk9PNnJhNzY1cS1VTTNfaA?oc=5","date":"2025-12-09","type":"deal","source":"Yahoo Finance Singapore","summary":"Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer - Yahoo Finance Singapore","headline":"Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Thera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNWFhqaE9OM3JJMXpCNGpfVjBGV3Y2UnYwVjZKZllzNnhDVHBYUXQ0Q0hKS0NYMVc5LWV3b1cxV21SWHZBVVBPMVN2bUlhOHY0VGpCTU5helVDZFFuRmY3VE1taFB0UTZmR3EyQ2RVSzZMVTQ3WDIteG5LS2tmclA2WVNLLVUtX292R1BtVmxwekJGQQ?oc=5","date":"2025-11-20","type":"trial","source":"Share Talk","summary":"hVIVO plc (AIM: HVO) secures £5m+ in new clinical trial contracts - Share Talk","headline":"hVIVO plc (AIM: HVO) secures £5m+ in new clinical trial contracts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNT05jWWlJVzl0V3VIT1JISGViOUdKZE4xWDJUbWlNT0tXSW5jMlZhZHlCX0pYLW9SeDg1RVNYa3ZyVlpmRW91UkVrNE9fSHIwX0wwSjlZUjVlZEp6WmlkN21jMG0tbENUSnpXMEx4ME02dDRCb0VHVU1rVkp1NjdUNGRTbE53c2dINkxraW5xTGN3SlotSmhuUQ?oc=5","date":"2025-11-03","type":"pipeline","source":"Share Talk","summary":"hVIVO plc (AIM: HVO) Presentation at Jefferies Healthcare Conference - Share Talk","headline":"hVIVO plc (AIM: HVO) Presentation at Jefferies Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNXzBzd0xzZmFhZndLbkM2UzJpSC0xZk5LRnVqOHN1QTBPS2ZNT2RzeC0ycmhZY2FfN0ttMzJuSkJ3QnRoRnRTTDhadXNfNUN5cUZWWV9kVlU0dXV2Qmxud1FPYWJuMWRXWGFSbzR5ckZNUDZsSWJVMWxKTVZEQ3ZQTWw2Nmh4ODVKMVB0VzVR?oc=5","date":"2025-03-19","type":"pipeline","source":"pharmaphorum","summary":"Roche taps Oxford BioTherapeutics for cancer drug discovery - pharmaphorum","headline":"Roche taps Oxford BioTherapeutics for cancer drug discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOM21NWGJUU3VHRnF1NzFjNk1RelV4RGVxWXVYN19jNGhVNjZIekt5YktjYTRBejRQeGE2VWd6V0RESG92eldPZms4RDlFZ0kxWmdtb0Z2ODFtR1ZTQWJCM0Nha0p4YXhoazJrdV9rYzVUVDlxTnAyVXRMOTdkeTR1S3ZyMDJ3TW4xU3lQa0pNY1dzeGt1R0E4Xy14bFlISWJkck1WRUdDMTFzOW5YOWlHalB5ZmpZcWR2dGxNNTEzbGhyUklaZWtWMG9fTWU1NGtPRWRIS3AyanphRFhaYmQtTGRIX21YNkRKYS1aUDNRbFFjWnN3Ti1GX3JOc3Y?oc=5","date":"2024-10-17","type":"pipeline","source":"PR Newswire","summary":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight - PR Newswire","headline":"200+ Pharma Companies Vie for the Top Spot in the Expanding Antibody-Drug Conjugate Oncology Market | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOMEhoakZpMHlVb3RyQmFfTlRuOFN4bmxJbHRNTW53MHZGOTdocFRpMnRMLXYyc0wyUmRxb2lRbjByQnp0N3JDNGtUdVVscG0zeFlkOFNUNllIMVF1MFhZZlJIZy1laUhYb1p5YUhBTVBKOVl3V01CYnZreURsV2kxcEdDc3UtU2JFRWc?oc=5","date":"2024-07-22","type":"pipeline","source":"Contract Pharma","summary":"Latigo Biotherapeutics Names New CEO - Contract Pharma","headline":"Latigo Biotherapeutics Names New CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOdEpwVnpRcENpMHFub256Qng2Q05QYmI0aC00bnRSRHphLWZxbE81R0pfd0pZWGdUWEc1bTVDY041UzFfWG1pUENBT3VtMWRzVG9pM25qRURiUmRqdV9EYXc2WEFGRXc3MlZyWjhPMld5TVdGQzQ5TllyVjVLYXJTbTFBWDJYdUt6OEFlZzNpVXNSRmN2M2VxSkdncWY?oc=5","date":"2021-01-07","type":"pipeline","source":"pharmaphorum","summary":"Oxford BioTherapeutics to research cell therapies for Gilead’s Kite - pharmaphorum","headline":"Oxford BioTherapeutics to research cell therapies for Gilead’s Kite","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQd0VwRUF2aXhtM0lqOFR4YjdhYk81TVUtSVdNTkR1cGx5eEdTb0pZcTU1a1dESmpCV2w4Nk9qaTZQMUdHOGhXYjVQcVF1VjV2MTQwQ09JUzJGN2ZBR2wtc0tBbWoxb0VjUHlucnFxbUdEQXJ4ZmtlQzNzZ3pLZ3phQXJ4ZGFVaURkUkJZS19mczhaNUxKbmRLUkthOHYyTmZhZjdzbHdoa0FSQWRPUDg1VnlFRU1QQQ?oc=5","date":"2020-10-14","type":"deal","source":"boehringer-ingelheim.com","summary":"Collaboration-with-OxfordBioTherapeutics - boehringer-ingelheim.com","headline":"Collaboration-with-OxfordBioTherapeutics - boehringer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}